LeMaitre Vascular to Present at Upcoming Investor Conferences
Get Alerts LMAT Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.4%
Revenue Growth %: +11.0%
Join SI Premium – FREE
BURLINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that it is participating in two investor conferences in November.
David Roberts, President, is scheduled to present at the Stifel Virtual Healthcare Conference on Monday, November 16, 2020, at 8:00 AM ET.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum on Thursday, November 19, 2020, at 9:30 AM ET.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Sandra Millar +1-781-425-1686 [email protected]Source: LeMaitre Vascular, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
- Cyngn Highlights 24-Patent Portfolio Anchoring Its Physical AI Platform
- Sachem Capital Corp. Announces Common and Preferred Dividends
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stifel, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share